Health Condition 1: null- postmenopausal osteoporosis
Conditions
Interventions
Intervention1: Lashuna tablets: DOSE 6 gms per day in 3 divided
doses
DOSAGE FORM Tablet (500mg)
ANUPANA Milk
ROUTE Oral
duration 12 weeks
Control Intervention1: Shatavari tablets: 6 gms per day in 3
Sponsors
PARUL INSTITUTE OF AYURVEDA
Eligibility
Inclusion criteria
Inclusion criteria: -Women of age group 40-60 years (Perimenopausal ,Menopausal, Post Menopausal age group) presentingoneormore risk factors ofdevelopingOsteoporosis. -Clinical symptoms of Osteoporosisand laboratoryinvestigations showing boneloss. -OsteoporoticfemalepatientswhoseBMD(t-score)isequaltoorlessthan-1willbe taken forthe present study. - Patients diagnosedto beOsteoporoticon the basisof Singhâ??sindex. - Patients presenting with the classical symptoms of Asthi Kshaya vis-a-via Osteoporosiswillbetaken for the study.
Exclusion criteria
Exclusion criteria: BMD â??tâ?? â??score above -1 will be excluded. • Patients suffering from neoplasm of the bone will be excluded. • Known cases of Diabetes mellitus, uncontrolled Hypertension, Thyrotoxicosis, Hyper Parathyroidism, Addisonâ??s disease, Pagetâ??s disease, Cushingâ??s syndrome, Tuberculosis of the bone, Osteomalacia, and Chronic Renal, Hepatic and Cardiac Failure will be excluded. • Rheumatoid Arthritis, Gouty Arthritis and any long-standing systemic disorder will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduces the post menopausal riskof osteoporosisTimepoint: reduces the post menopausal riskof osteoporosis | — |
Secondary
| Measure | Time frame |
|---|---|
| reduce pain,improves the quality of lifeTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDR MANSI MODI
Parul Institute Of Ayurveda
Outcome results
None listed